Funding History

NanoVir's promising research into DNA-targeted treatments for HPV has been consistently recognized by the scientific funding community. ( To see issued  patent, click here.)

2008 -2010
Phase 2 STTR Grant - $3,000,000
This grant will enable development of broad spectrum anti HPV compounds

RO1 Grant - $1,830,000
This grant allows basic studies of antiviral mechanisms of actions

Phase 2 STTR Grant - $2,980,000
This grant will allow development of an antiviral treatment for HPV16

2007
Phase 1 STTR - $980,000
Allows identification of compound targeting HPV 18

2004
Phase 1 STTR - $780,000
Enables initial targeting of HPV 16

Bioscience Research & Commercialization Center - $218,000
HPV research